sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Non-Invasive Liquid Biopsy Market Growth (Status and Outlook) 2021-2026

Global Non-Invasive Liquid Biopsy Market Growth (Status and Outlook) 2021-2026

Home / Categories / Healthcare
Global Non-Invasive Liquid Biopsy Market Growth (Status and Outlook) 2021-2026
Global Non-Invasive Liquid Biopsy Market...
Report Code
RO1/109/1419

Publish Date
22/Jan/2022

Pages
212
PRICE
$ 3660/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 4490/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 6320/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-Invasive Liquid Biopsy Market Size 2016-2026
2.1.2 Non-Invasive Liquid Biopsy Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Non-Invasive Liquid Biopsy Segment by Type
2.2.1 Stool Test
2.2.2 Stool Test
2.2.3 Saliva Test
2.2.4 Others
2.3 Non-Invasive Liquid Biopsy Market Size by Type
2.3.1 Global Non-Invasive Liquid Biopsy Market Size CAGR by Type
2.3.2 Global Non-Invasive Liquid Biopsy Market Size Market Share by Type (2016-2021)
2.4 Non-Invasive Liquid Biopsy Segment by Application
2.4.1 Hospital
2.4.2 Laboratory
2.4.3 Others
2.5 Non-Invasive Liquid Biopsy Market Size by Application
2.5.1 Global Non-Invasive Liquid Biopsy Market Size CAGR by Application
2.5.2 Global Non-Invasive Liquid Biopsy Market Size Market Share by Application (2016-2021)

3 Non-Invasive Liquid Biopsy Market Size by Players
3.1 Non-Invasive Liquid Biopsy Market Size Market Share by Players
3.1.1 Global Non-Invasive Liquid Biopsy Revenue by Players (2019-2021E)
3.1.2 Global Non-Invasive Liquid Biopsy Revenue Market Share by Players (2019-2021E)
3.2 Global Non-Invasive Liquid Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Non-Invasive Liquid Biopsy by Regions
4.1 Non-Invasive Liquid Biopsy Market Size by Regions (2016-2021)
4.2 Americas Non-Invasive Liquid Biopsy Market Size Growth (2016-2021)
4.3 APAC Non-Invasive Liquid Biopsy Market Size Growth (2016-2021)
4.4 Europe Non-Invasive Liquid Biopsy Market Size Growth (2016-2021)
4.5 Middle East & Africa Non-Invasive Liquid Biopsy Market Size Growth (2016-2021)

5 Americas
5.1 Americas Non-Invasive Liquid Biopsy Market Size by Country (2016-2021)
5.2 Americas Non-Invasive Liquid Biopsy Market Size by Type (2016-2021)
5.3 Americas Non-Invasive Liquid Biopsy Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Non-Invasive Liquid Biopsy Market Size by Region (2016-2021)
6.2 APAC Non-Invasive Liquid Biopsy Market Size by Type (2016-2021)
6.3 APAC Non-Invasive Liquid Biopsy Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Non-Invasive Liquid Biopsy by Country (2016-2021)
7.2 Europe Non-Invasive Liquid Biopsy Market Size by Type (2016-2021)
7.3 Europe Non-Invasive Liquid Biopsy Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Non-Invasive Liquid Biopsy by Region (2016-2021)
8.2 Middle East & Africa Non-Invasive Liquid Biopsy Market Size by Type (2016-2021)
8.3 Middle East & Africa Non-Invasive Liquid Biopsy Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Non-Invasive Liquid Biopsy Market Forecast
10.1 Global Non-Invasive Liquid Biopsy Forecast by Regions (2021-2026)
10.1.1 Global Non-Invasive Liquid Biopsy Forecast by Regions (2021-2026)
10.1.2 Americas Non-Invasive Liquid Biopsy Forecast
10.1.3 APAC Non-Invasive Liquid Biopsy Forecast
10.1.4 Europe Non-Invasive Liquid Biopsy Forecast
10.1.5 Middle East & Africa Non-Invasive Liquid Biopsy Forecast
10.2 Americas Non-Invasive Liquid Biopsy Forecast by Countries (2021-2026)
10.2.1 United States Non-Invasive Liquid Biopsy Market Forecast
10.2.2 Canada Non-Invasive Liquid Biopsy Market Forecast
10.2.3 Mexico Non-Invasive Liquid Biopsy Market Forecast
10.2.4 Brazil Non-Invasive Liquid Biopsy Market Forecast
10.3 APAC Non-Invasive Liquid Biopsy Forecast by Region (2021-2026)
10.3.1 China Non-Invasive Liquid Biopsy Market Forecast
10.3.2 Japan Non-Invasive Liquid Biopsy Market Forecast
10.3.3 Korea Non-Invasive Liquid Biopsy Market Forecast
10.3.4 Southeast Asia Non-Invasive Liquid Biopsy Market Forecast
10.3.5 India Non-Invasive Liquid Biopsy Market Forecast
10.3.6 Australia Non-Invasive Liquid Biopsy Market Forecast
10.4 Europe Non-Invasive Liquid Biopsy Forecast by Country (2021-2026)
10.4.1 Germany Non-Invasive Liquid Biopsy Market Forecast
10.4.2 France Non-Invasive Liquid Biopsy Market Forecast
10.4.3 UK Non-Invasive Liquid Biopsy Market Forecast
10.4.4 Italy Non-Invasive Liquid Biopsy Market Forecast
10.4.5 Russia Non-Invasive Liquid Biopsy Market Forecast
10.5 Middle East & Africa Non-Invasive Liquid Biopsy Forecast by Region (2021-2026)
10.5.1 Egypt Non-Invasive Liquid Biopsy Market Forecast
10.5.2 South Africa Non-Invasive Liquid Biopsy Market Forecast
10.5.3 Israel Non-Invasive Liquid Biopsy Market Forecast
10.5.4 Turkey Non-Invasive Liquid Biopsy Market Forecast
10.5.5 GCC Countries Non-Invasive Liquid Biopsy Market Forecast
10.6 Global Non-Invasive Liquid Biopsy Forecast by Type (2021-2026)
10.7 Global Non-Invasive Liquid Biopsy Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Bio-Techne
11.1.1 Bio-Techne Company Information
11.1.2 Bio-Techne Non-Invasive Liquid Biopsy Product Offered
11.1.3 Bio-Techne Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Bio-Techne Main Business Overview
11.1.5 Bio-Techne Latest Developments
11.2 Endress+Hauser
11.2.1 Endress+Hauser Company Information
11.2.2 Endress+Hauser Non-Invasive Liquid Biopsy Product Offered
11.2.3 Endress+Hauser Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Endress+Hauser Main Business Overview
11.2.5 Endress+Hauser Latest Developments
11.3 Exact Sciences Corporation
11.3.1 Exact Sciences Corporation Company Information
11.3.2 Exact Sciences Corporation Non-Invasive Liquid Biopsy Product Offered
11.3.3 Exact Sciences Corporation Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Exact Sciences Corporation Main Business Overview
11.3.5 Exact Sciences Corporation Latest Developments
11.4 Lonza Group AG
11.4.1 Lonza Group AG Company Information
11.4.2 Lonza Group AG Non-Invasive Liquid Biopsy Product Offered
11.4.3 Lonza Group AG Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Lonza Group AG Main Business Overview
11.4.5 Lonza Group AG Latest Developments
11.5 MDxHealth
11.5.1 MDxHealth Company Information
11.5.2 MDxHealth Non-Invasive Liquid Biopsy Product Offered
11.5.3 MDxHealth Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 MDxHealth Main Business Overview
11.5.5 MDxHealth Latest Developments
11.6 Merck KGaA
11.6.1 Merck KGaA Company Information
11.6.2 Merck KGaA Non-Invasive Liquid Biopsy Product Offered
11.6.3 Merck KGaA Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Merck KGaA Main Business Overview
11.6.5 Merck KGaA Latest Developments
11.7 MutantDx
11.7.1 MutantDx Company Information
11.7.2 MutantDx Non-Invasive Liquid Biopsy Product Offered
11.7.3 MutantDx Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 MutantDx Main Business Overview
11.7.5 MutantDx Latest Developments
11.8 Norgen Biotek Corp
11.8.1 Norgen Biotek Corp Company Information
11.8.2 Norgen Biotek Corp Non-Invasive Liquid Biopsy Product Offered
11.8.3 Norgen Biotek Corp Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Norgen Biotek Corp Main Business Overview
11.8.5 Norgen Biotek Corp Latest Developments
11.9 Nucleix
11.9.1 Nucleix Company Information
11.9.2 Nucleix Non-Invasive Liquid Biopsy Product Offered
11.9.3 Nucleix Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Nucleix Main Business Overview
11.9.5 Nucleix Latest Developments
11.10 Oasis Diagnostics Corporation
11.10.1 Oasis Diagnostics Corporation Company Information
11.10.2 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Product Offered
11.10.3 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Oasis Diagnostics Corporation Main Business Overview
11.10.5 Oasis Diagnostics Corporation Latest Developments
11. OraSure Technologies
11.11.1 OraSure Technologies Company Information
11.11.2 OraSure Technologies Non-Invasive Liquid Biopsy Product Offered
11.11.3 OraSure Technologies Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 OraSure Technologies Main Business Overview
11.11.5 OraSure Technologies Latest Developments
11.12 PerkinElmer
11.12.1 PerkinElmer Company Information
11.12.2 PerkinElmer Non-Invasive Liquid Biopsy Product Offered
11.12.3 PerkinElmer Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 PerkinElmer Main Business Overview
11.12.5 PerkinElmer Latest Developments
11.13 Predicine
11.13.1 Predicine Company Information
11.13.2 Predicine Non-Invasive Liquid Biopsy Product Offered
11.13.3 Predicine Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Predicine Main Business Overview
11.13.5 Predicine Latest Developments
11.14 Qiagen
11.14.1 Qiagen Company Information
11.14.2 Qiagen Non-Invasive Liquid Biopsy Product Offered
11.14.3 Qiagen Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Qiagen Main Business Overview
11.14.5 Qiagen Latest Developments
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Information
11.15.2 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Product Offered
11.15.3 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Thermo Fisher Scientific Main Business Overview
11.15.5 Thermo Fisher Scientific Latest Developments
11.16 Zymo Research Corporation
11.16.1 Zymo Research Corporation Company Information
11.16.2 Zymo Research Corporation Non-Invasive Liquid Biopsy Product Offered
11.16.3 Zymo Research Corporation Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Zymo Research Corporation Main Business Overview
11.16.5 Zymo Research Corporation Latest Developments

12 Research Findings and Conclusion

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com